Transplantation

Anti-pig IgE and IgA Antibodies in Naive Primates and Nonhuman Primates With Pig Xenografts.  105:318-327. 2021

Cardiac Mortality Following Kidney Transplantation: Progress Made But Still Room for Improvement.  105:278-279. 2021

Center-level Variation in HLA-incompatible Living Donor Kidney Transplantation Outcomes.  105:436-442. 2021

The Role of SLAs in Xenotransplantation.  105:300-307. 2021

Suggested Patient Selection Criteria for Initial Clinical Trials of Pig Kidney Xenotransplantation in the USA. 2021

A Video Intervention to Increase Organ Donor Registration at the Department of Motorized Vehicles.  104:788-794. 2020

Enhanced Advocacy and Health Systems Training through Patient Navigation Increases Access to Living-donor Kidney Transplantation.  122-129. 2020

Geographic differences in population health and expected organ supply in the Gulf Coast Region of the United States compared to non-Gulf States.  421-427. 2020

Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?.  1215-1228. 2020

Late Graft Loss after Kidney Transplantation: Is "death with Function" Really Death with a Functioning Allograft?.  1483-1490. 2020

Social determinants of health: Going beyond the basics to explore racial disparities in kidney transplantation.  1324-1325. 2020

Life-supporting Kidney Xenotransplantation from Genetically Engineered Pigs in Baboons: A Comparison of Two Immunosuppressive Regimens.  103:2090-2104. 2019

Center variation and risk factors for failure to complete 6 month postdonation follow-up among obese living kidney donors.  103:1450-1456. 2019

Ethnic and age disparities in outcomes among liver transplant waitlist candidates.  103:1425-1432. 2019

Establishing a core outcome measure for life participation: A standardized outcomes in nephrology-kidney transplantation consensus workshop report.  103:1199-1205. 2019

Perspectives on the Optimal Genetically Engineered Pig in 2018 for Initial Clinical Trials of Kidney or Heart Xenotransplantation.  102:1974-1982. 2018

Population Health, Ethnicity, and Rate of Living Donor Kidney Transplantation.  102:2080-2087. 2018

Overcoming Coagulation Dysregulation in Pig Solid Organ Transplantation in Nonhuman Primates: Recent Progress.  102:1050-1058. 2018

Immune Responses of HLA Highly Sensitized and Nonsensitized Patients to Genetically Engineered Pig Cells.  102:e195-e204. 2018

Intraoperative Management of Liver Transplant Patients Without the Routine Use of Renal Replacement Therapy.  102:e229-e235. 2018

Long Cold Ischemia Times in Same Hospital Deceased Donor Transplants.  102:471-477. 2018

Patient and Kidney Allograft Survival in Recipients with End-Stage Renal Disease from Amyloidosis.  102:300-309. 2018

Living Kidney Donor Phenotype and Likelihood of Postdonation Follow-up.  102:135-139. 2018

An Investigation of Extracellular Histones in Pig-To-Baboon Organ Xenotransplantation.  101:2330-2339. 2017

Regulation of Clinical Xenotransplantation-Time for a Reappraisal.  101:1766-1769. 2017

Selection of Patients for Initial Clinical Trials of Solid Organ Xenotransplantation.  101:1551-1568. 2017

A Difficult Decision: Atypical JC Polyomavirus Encephalopathy in a Kidney Transplant Recipient..  101:1461-1467. 2017

Cost-effectiveness of antibody-based induction therapy in deceased donor kidney transplantation in the United States.  101:1234-1241. 2017

Progress in Clinical Encapsulated Islet Xenotransplantation.  100:2301-2308. 2016

Pig Liver Xenotransplantation: A Review of Progress Toward the Clinic.  100:2039-2047. 2016

Executive summary of IPITA-TTS opinion leaders report on the future of b-cell replacement.  100:e25-e31. 2016

Long-Term Renal Function in Living Kidney Donors Who Had Histological Abnormalities at Donation.  100:1294-1298. 2016

APOL1 genotype and kidney transplantation outcomes from deceased african American donors.  100:194-202. 2016

Eomesoderminlo CTLA4^hi Alloreactive CD8+ Memory T Cells Are Associated with Prolonged Renal Transplant Survival Induced by Regulatory Dendritic Cell Infusion in CTLA4 Immunoglobulin-Treated Nonhuman Primates.  100:91-102. 2016

Long-Term outcomes after liver transplantation among human immunodeficiency virus-infected recipients.  100:141-146. 2016

Report from IPITA-TTS opinion leaders meeting on the future of β-cell replacement.  100:S1-S44. 2016

The kidney-vascular-bone axis in the chronic kidney disease-mineral bone disorder.  100:497-505. 2016

David K. C. Cooper, MD, PhD: Professor of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh, PA.  99:1310-1311. 2015

Choosing the order of deceased donor and living donor kidney transplantation in pediatric recipients: A Markov decision process model.  99:360-366. 2015

Center-level variation in the development of delayed graft function after deceased donor kidney transplantation.  99:997-1002. 2015

Frailty, mycophenolate reduction, and graft loss in kidney transplant recipients.  99:805-810. 2015

Islet size index as a predictor of outcomes in clinical islet autotransplantation.  97:1286-1291. 2014

The authors' reply.  97. 2014

Resource utilization associated with procurement of transplantable organs from donors that do not meet OPTN eligible death criteria.  97:1043-1048. 2014

Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipients.  97:846-853. 2014

Increased soluble CD154 (CD40 Ligand) levels in xenograft recipients correlate with the development of de novo anti-pig IgG antibodies.  97:502-508. 2014

Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients.  97:446-450. 2014

Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation.  98:857-863. 2014

Thyroid hormone therapy in the management of 63,593 brain-dead organ donors: A retrospective analysis.  98:1019. 2014

Thyroid hormone therapy in the management of 63,593 brain-dead organ donors: A retrospective analysis.  98:1119-1127. 2014

New concepts of immune modulation in xenotransplantation.  96:937-945. 2013

Order of donor type in pediatric kidney transplant recipients requiring retransplantation.  96:487-493. 2013

Hepatitis C virus infection in heart transplantation: Is ventricular assist device therapy an option?.  96. 2013

Is there a correlation between anti-pig antibody levels in humans and geographic location during childhood?.  96:387-393. 2013

Outcomes in systemic sclerosis-related lung disease after lung transplantation.  95:975-980. 2013

Erratum: Is decedent race an independent predictor of organ donor consent or merely a surrogate marker of socioeconomic status (Transplantation (2012) 2:94 (873)).  95. 2013

Ganciclovir prophylaxis improves late murine cytomegalovirus-induced renal allograft damage.  95:48-53. 2013

A syndrome of severe hypoglycemia and acidosis in young immunosuppressed diabetic monkeys and pigs-association with sepsis.  94:1187-1191. 2012

Is decedent race an independent predictor of organ donor consent or merely a surrogate marker of socioeconomic status?.  94:873-878. 2012

Review of cytomegalovirus infection findings with mammalian target of rapamycin inhibitor-based immunosuppressive therapy in de novo renal transplant recipients.  93:1075-1085. 2012

Reply to "genetic determinants of mycophenolate-related anemia and leukopenia after transplantation".  93. 2012

T-cell-based immunosuppressive therapy inhibits the development of natural antibodies in infant baboons.  93:769-776. 2012

Total lymphoid irradiation in heart transplantation: Long-term efficacy and survival-an 18-year experience.  92:1159-1164. 2011

African American living-kidney donors should be screened for apol1 risk alleles.  92:722-725. 2011

Ganciclovir transiently attenuates murine cytomegalovirus-associated renal allograft inflammation.  92:759-766. 2011

Genetic determinants of mycophenolate-related anemia and leukopenia after transplantation.  91:309-316. 2011

Novel polymorphisms associated with tacrolimus trough concentrations: Results from a multicenter kidney transplant consortium.  91:300-308. 2011

Optimal cutoff point for immunoperoxidase detection of C4d in the renal allograft: Results from a multicenter study.  90:1099-1105. 2010

The spleen as a site for hematopoiesis.  90:1040-1041. 2010

Non-human primate regulatory T cells: Current biology and implications for transplantation.  90:811-816. 2010

Hepatic function after genetically engineered pig liver transplantation in baboons.  90:483-493. 2010

Evidence for antibody-mediated injury as a Major determinant of late kidney allograft failure.  90:68-74. 2010

Pig liver xenotransplantation as a bridge to allotransplantation: Which patients might benefit?.  88:1041-1049. 2009

ABO incompatible renal transplantation: A paradigm ready for broad implementation.  87:1246-1255. 2009

Adenovirus infection activates akt1 and induces cell proliferation in pancreatic islets1.  87:821-824. 2009

The innate immune response and activation of coagulation in ±1,3-galactosyltransferase gene-knockout xenograft recipients.  87:805-812. 2009

Hormonal therapy to the brain-dead potential organ donor: The misnomer of the "papworth cocktail".  86:1479. 2008

Suppressive efficacy and proliferative capacity of human regulatory t cells in allogeneic and xenogeneic responses.  86:1452-1462. 2008

Atorvastatin down-regulates the primate cellular response to porcine aortic endothelial cells in vitro.  86:733-737. 2008

Expression of tissue factor and initiation of clotting by human platelets and monocytes after incubation with porcine endothelial cells.  86:702-709. 2008

Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: Ineffective usage of renal allografts.  85:935-942. 2008

Retraction: Peritransplant tolerance induction with anti-CD3-immunotoxin: A matter of proinflammatory cytokine control (Transplantation (1998) 65, 9, (1159-1169)).  85:920. 2008

ABO-incompatible transplantation: Less may be more.  84. 2007

The impact of left ventricular systolic dysfunction on survival after renal transplantation.  84:1610-1617. 2007

Response to commentaries on "α1,3-galactosyltransferase gene-knockout pigs for xenotransplantation: Where do we go from here?".  84:1212-1213. 2007

α1,3-galactosyltransferase gene-knockout pigs for xenotransplantation: Where do we go from here?.  84:1-7. 2007

Gene expression of porcine lymphotrophic herpesvirus-1 in miniature swine with posttransplant lymphoproliferative disorder.  83:87-90. 2007

Is xenotransplantation of embryonic stem cells a realistic option?.  83:333-335. 2007

Reduction of early graft loss after intraportal porcine islet transplantation in monkeys.  83:202-210. 2007

Factors affecting graft survival after liver transplantation from donation after cardiac death donors.  82:1683-1688. 2006

Hormonal therapy of the brain-dead organ donor: Experimental and clinical studies.  82:1396-1401. 2006

Allosensitization does not increase the risk of xenoreactivity to α1,3-galactosyltransferase gene-knockout miniature swine in patients on transplantation waiting lists.  82:314-319. 2006

Liver and kidney transplantation for polycystic liver and kidney-renal function and outcome.  82:501-507. 2006

Elicited antibodies in baboons exposed to tissues from α1,3-galactosyltransferase gene-knockout pigs.  81:1058-1062. 2006

Immunological unresponsiveness in chimeric miniature swine following MHC-mismatched spleen transplantation.  80:1791-1804. 2005

alpha1,3-Galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months..  80:1493-1500. 2005

Posttransplant lymphoproliferative disorder among renal transplant patients in relation to the use of mycophenolate mofetil.  80:1174-1180. 2005

α1,3-galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months.  80:1493-1500. 2005

Mycophenolate mofetil: Ten years of clinical experience. Introduction.  80. 2005

Can cold or heat shock improve skeletal myoblast engraftment in infarcted myocardium?.  80:660-665. 2005

Cadaveric orthotopic auxiliary split liver transplantation and kidney transplantation: An alternative for type 1 primary hyperoxaluria.  80:421-424. 2005

United Network for Organ Sharing publication on scientific registry of transplant recipients central nervous system donor cancer transmission data [4].  79:623. 2005

Inhibition of cellular immune responses to encapsulated porcine islet xenografts by simultaneous blockade of two different costimulatory pathways.  79:409-418. 2005

Porcine hematopoietic progenitor cell transplantation in nonhuman primates: A review of progress.  79:1-9. 2005

Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: A report from the Israel penn international transplant tumor registry.  78:1676-1682. 2004

T cells from presensitized donors fail to cause graft-versus-host disease in a pig-to-mouse xenotransplantation model.  78:1609-1617. 2004

Reduction of consumptive coagulopathy using porcine cytomegalovirus-free cardiac porcine grafts in pig-to-primate xenotransplantation.  78:1449-1453. 2004

Two-dose daclizumab induction therapy in 209 liver transplants: A single-center analysis.  78:1212-1217. 2004

Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma.  78:972-977. 2004

α1-3-galactosyltransferase gene-knockout miniature swine produce natural cytotoxic anti-gal antobodies.  78:15-20. 2004

Acute vascular rejection of xenografts: Roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity.  77:1735-1741. 2004

Leflunomide therapy for cytomegalovirus disease in renal allograft recepients.  77:1460-1461. 2004

Right donor nephrectomy: A comparison of hand-assisted transperitoneal and retroperitoneal laparoscopic approaches.  77:521-525. 2004

West Nile virus encephalitis in organ transplant recipients: Another high-risk group for meningoencephalitis and death?.  77:466-469. 2004

Alloantibody and xenoantibody cross-reactivity in transplantation.  77:1-5. 2004

Posttransplant lymphoproliferative disease after allogeneic transplantation of the spleen in miniature swine..  78:286-291. 2004

The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation.  76:1583-1588. 2003

Graft protective effects of heme oxygenase 1 in mouse tracheal transplant-related obliterative bronchiolitis.  76:650-656. 2003

Donors with central nervous system malignancies: Are they truly safe?.  76:340-343. 2003

Allogeneic bone marrow inhibits T-cell activation and clonal expansion in vitro.  76:237-243. 2003

Double genetic modification of adenovirus fiber with RGD polylysine motifs significantly enhances gene transfer to isoiated human pancreatic islets.  76:252-261. 2003

Porcine cytomegalovirus and coagulopathy in pig-to-primate xenotransplantation.  75:1841-1847. 2003

Spleen transplantation in miniature swine: Surgical technique and results in major histocompatibility complex-matched donor and recipient pairs.  75:1799-1806. 2003

Xenogeneic thymokidney and thymic tissue transplantation in a pig-to-baboon model: I. Evidence for pig-specific T-cell unresponsiveness.  75:1615-1624. 2003

Xenogeneic thymus transplantation in a pig-to-baboon model.  75:282-291. 2003

MALToma: A Helicobacter pylori-associated malignancy in transplant patients: A report from the Israel Penn International Transplant Tumor Registry with a review of published literature.  75:225-228. 2003

Bone mineral density changes within six months of renal transplantation.  75:49-54. 2003

Bone mineral density changes within six months of renal transplantation..  75:49-54. 2003

Liver transplant-associated graft-versus-host disease.  75:118-126. 2003

Maximizing renal artery length in right laparoscopic donor nephrectomy by retrocaval exposure of the aortorenal junction.  75:83-85. 2003

17β-estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: Molecular mechanisms and islet functionality.  74:1252-1259. 2002

Cryopreservation and mycophenolate therapy are detrimental to hematopoietic progenitor cells.  74:1159-1166. 2002

Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders.  74:1090-1095. 2002

Simvastatin induces activation of the serine-threonine protein kinase Akt and increases survival of isolated human pancreatic islets.  74:1063-1069. 2002

The nondirected live-kidney donor: Ethical considerations and practice guidelines. A national conference report.  74:582-589. 2002

Activation of human endothelial cells by mobilized porcine leukocytes in vitro: Implications for mixed chimerism in xenotransplantation.  73:1302-1309. 2002

Chlamydia pneumoniae respiratory infection after allogeneic stem cell transplantation.  73:1002-1005. 2002

Depletion of anti-gal antibodies in baboons by intravenous therapy with bovine serum albumin conjugated to Gal oligosaccharides.  73:129-139. 2002

Pig hematopoietic cell chimerism in baboons conditioned with a nonmyeloablative regimen and CD154 blockade.  73:12-22. 2002

Xenotransplantation so close, but yet so far.  73:1-2. 2002

Anti-CD154 monoclonal antibody and thromboembolism revisited [2].  74:416-417. 2002

CD40-CD154 pathway blockade requires host macrophages to induce humoral unresponsiveness to pig hematopoietic cells in baboons.  72:1759-1768. 2001

Pig kidney transplantation in baboons: Anti-galα1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation.  72:1743-1752. 2001

Clearance of mobilized porcine peripheral blood progenitor cells is delayed by depletion of the phagocytic reticuloendothelial system in baboons.  72:1278-1285. 2001

Modulation of platelet aggregation in baboons: Implications for mixed chimerism in xenotransplantation. I. The roles of individual components of a transplantation conditioning regimen and of pig peripheral blood progenitor cells.  72:1299-1305. 2001

Modulation of platelet aggregation in baboons: Implications for mixed chimerism in xenotransplantation. II. The effects of cyclophosphamide on pig peripheral blood progenitor cell-induced aggregation.  72:1306-1310. 2001

An essential role for natural killer cells in augmentation of allograft survival mediated by donor spleen cells.  72:954-956. 2001

Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection.  71:1772-1776. 2001

Mechanisms of thrombotic microangiopathy following xenogeneic hematopoietic progenitor cell transplantation.  71:1601-1609. 2001

Tolerance in renal transplantation after allogeneic bone marrow transplantation-6-year follow-up.  71:1681-1683. 2001

Anti-CD154 monoclonal antibody and thromboembolism.  71:491. 2001

The role of anti-Galα1-3Gal antibodies in acute vascular rejection and accommodation of xenografts.  70:1667-1674. 2000

Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates.  70:1323-1331. 2000

Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates. Transplantation 2000; 70:1323.  70:1273-1274. 2000

A differential requirement for CD8⁺ donor cells in the augmentation of allograft survival by posttransplantation administration of donor spleen cells and donor bone marrow cells.  70:1068-1073. 2000

Long-term results of liver transplantation in patients 60 years of age and older.  70:780-783. 2000

Are pigs transgenic for human complement regulatory proteins necessary for xenotransplantation.  70:567-568. 2000

Opening of mitochondrial potassium channels: A new target for graft preservation strategies?.  70:576-578. 2000

High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response.  69:2296-2304. 2000

Significance of blood stream infection after lung transplantation: Analysis in 176 consecutive patients.  69:2360-2366. 2000

Gene therapy and transplantation.  69:1995-1999. 2000

The safety and efficacy of a two-dose daclizumab (Zenapax) induction therapy in liver transplant recipients.  69:1867-1872. 2000

Anti-Galα1-3Gal antibody levels in organ transplant recipients receiving immunosuppressive therapy.  69:914-917. 2000

Enhanced allograft survival induced by posttransplant donor spleen cell infusion occurs via a mechanism that is distinct from the mechanism of enhancement by donor bone marrow.  69:1020-1022. 2000

Posttransplant lymphoproliferative disorder localized near the allograft in renal transplantation.  69:809-814. 2000

Hepatopulmonary syndrome and venous emboli causing intracerebral hemorrhages after liver transplantation: A case report.  68:1809-1811. 1999

Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: A phase II trial.  68:1526-1532. 1999

Cytomegalovirus infection and posttransplant lymphoproliferative disease in renal transplant recipients: Results of the U.S. multicenter FK506 kidney transplant study group.  68:1203-1205. 1999

Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: A randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine - Results at six months after transplantation.  68:663-671. 1999

Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection.  68:310-313. 1999

Tolerability and side effects of anti-CD3-immunotoxin in preclinical testing in kidney and pancreatic islet transplant recipients.  68:215-219. 1999

Screening by tRNA primer extension analysis of porcine kidney mRNA libraries defines a novel endogenous porcine retroviral long terminal repeat.  67:1391-1395. 1999

Transfer of swine major histocompatibility complex class II genes into autologous bone marrow cells of baboons for the induction of tolerance across xenogeneic barriers.  67:1119-1128. 1999

Long-term discordant xenogeneic (porcine-to-primate) bone marrow engraftment in a monkey treated with porcine-specific growth factors.  67:972-977. 1999

Serum cytotoxicity to pig cells and anti-αGal antibody level and specificity in humans and baboons.  67:658-665. 1999

Brain death and its influence on donor organ quality and outcome after transplantation.  67:343-348. 1999

Immunoregulatory role of CD8alpha in the veto effect..  67:372-380. 1999

Immunoregulatory role of CD8α in the veto effect: Transforming growth factor-b1 activation.  67:372-380. 1999

Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption.  67:18-30. 1999

Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts.  66:1439-1450. 1998

Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: Is chronic rejection part of the disease process?.  66:1300-1306. 1998

PRIMARY NONFUNCTION: IS IT DUE TO IMPAIRED MITOCHONDRIAL AT SYNTHESIS?.  66:S8-S8. 1998

Discordant organ xenotransplantation in primates: World experience and current status.  66:547-561. 1998

A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients.  66:507-515. 1998

Anti-Galα1-3Gal antibody response to porcine bone marrow in unmodified baboons and baboons conditioned for tolerance induction.  66:176-182. 1998

Results of the double-blind, randomized, multicenter, phase III clinical trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.  66:29-37. 1998

Peritransplant tolerance induction with anti-CD3 immunotoxin: A matter of proinflammatory cytokine control.  65:1159-1169. 1998

Long-term outcome of patients transplanted with livers from hepatitis C- positive donors.  65:925-929. 1998

Commentary on a comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation (multiple letters).  65:142-145. 1998

Intravenous infusion of Galα1-3Gal oligosaccharides in baboons delays hyperacute rejection of porcine heart xenografts.  65:346-353. 1998

Mycophenolate mofetil for the treatment of a first acute renal allograft rejection.  65:235-241. 1998

Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galα1-3Galβ1-4βGlc-X immunoaffinity column.  65:172-179. 1998

Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation.  65:180-187. 1998

Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy.  64:1255-1261. 1997

Protective effect of reduced glutathione on endothelial function of coronary arteries subjected to prolonged cold storage.  64:660-663. 1997

A molecular epidemiological probe for pig microchimerism.  64:347-350. 1997

Split tolerance induced by immunotoxin in a rhesus kidney allograft model.  63:1339-1345. 1997

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation.  63:977-983. 1997

Immunolocalization of acidic fibroblast growth factor and receptors in the tubulointerstitial compartment of chronically rejected human renal allografts.  63:988-995. 1997

Anti-GAL IgG antibodies in sera of newborn humans and baboons and its significance in pig xenotransplantation.  63:182-186. 1997

FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts.  63:1-6. 1997

In vivo immunoadsorption of antipig antibodies in baboons using a specific Galα1-3Gal column.  62:1379-1384. 1996

Glycans derived from porcine stomach mucin are effective inhibitors of natural anti-α-galactosyl antibodies in vitro and after intravenous infusion in baboons.  62:1324-1331. 1996

Monoclonal antiidiotypic antibodies neutralize cytotoxic effects of anti-αGal antibodies.  62:837-843. 1996

A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection.  62:594-599. 1996

Cobra venom factor stimulates anti-α-galactose antibody production in baboons: Implications for pig-to-human xenotransplantation.  62:678-681. 1996

Immunolocalization of FGF-1 and receptors in human renal allograft vasculopathy associated with chronic rejection.  62:467-475. 1996

Immunolocalization of FGF-1 and receptors in glomerular lesions associated with chronic human renal allograft rejection.  62:190-200. 1996

Immunosuppressive effects of an HLA class I-derived peptide in a rat cardiac allograft model.  61:1222-1228. 1996

Characterization of baboon class I major histocompatibility molecules: Implications for baboon-to-human xenotransplantation.  61:989-996. 1996

Molecular conjugate-mediated gene transfer into isolated human kidneys.  61:812-817. 1996

Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection.  61:722-729. 1996

Pentoxifylline does not prevent the cytokine-induced first dose reaction following OKT3 - A randomized, double-blind placebo-controlled study.  61:573-577. 1996

Impact of donor/recipient size matching on outcomes in renal transplantation.  61:383-388. 1996

Gas-generating systems in acute renal allograft rejection in the rat: Co-induction of heme oxygenase and nitric oxide synthase.  61:93-98. 1996

Pretransplant status and patient survival following liver transplantation.  60:920-925. 1995

Newborn baboon serum anti-αgalactosyl antibody levels and cytotoxicity to cultured pig kidney (PK15) cells.  60:520-521. 1995

Evaluation of living renal donors: The current practice of US transplant centers.  60:322-327. 1995

Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients.  60:225-232. 1995

Risk factors affecting second renal transplant outcome, with special reference to primary allograft nephrectomy.  60:138-144. 1995

Secondary organ allografting after a primary “bridging” xenotransplant.  60:19-22. 1995

Auxiliary liver allografting and xenografting in the nonhuman primate.  59:1670-1676. 1995

A rapid flow cytometry assay for hla antibody detection using a pooled cell panel covering 14 serological crossreacting groups.  59:626-630. 1995

The predictive value of hepatocyte glycogen content on liver allograft biopsy: Correlation with early graft function.  59:141-143. 1995

Direct assessment of the antioxidant effects of a new heart preservation solution, celsior: A hemodynamic and electron spin resonance study.  58:739-742. 1994

Evidence that intravenously administered a-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (pk15) and transplanted pig hearts.  58:330-337. 1994

Protection of pig kidney (pk15) cells from the cytotoxic effect of anti-pig antibodies by α-galactosyl oligosaccharides.  57:959-963. 1994

Renal retransplantation: The role of race, quadruple immunosuppression, and the flow cytometry cross-match.  57:47-54. 1994

The incidence of subsequent acute rejection following the treatment of refractory renal allograft rejection with mycophenolate mofetil (RS61443).  57:640-643. 1994

The pig as a potential organ donor for man: A study of potentially transferable disease from donor pig to recipient man.  57:694-703. 1994

Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation.  56:1433-1442. 1993

OKT3 rescue for steroid-resistant rejection in adult liver transplantation.  55:87-91. 1993

Regulation of cytokine-stimulated vascular cell adhesion molecule-1 expression in renal tubular epithelial cells.  55:172-177. 1993

Specific intravenous carbohydrate therapy: A new concept in inhibiting antibody-mediated rejection - Experience with ABO-incompatible cardiac allografting in the baboon.  56:769-777. 1993

Cytomegalovirus disease in heart transplant patients.  53:1167-1168. 1992

Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression.  53:103-109. 1992

Proliferation of cytomegalovirus-primed lymphocytes in bronchoalveolar lavages from lung transplant patients.  54:635-639. 1992

Rs-61443—a phase i clinical trial and pilot rescue study.  53:428-432. 1992

Social rehabilitation and return to work after cardiac transplantation—a multicenter survey.  53:433-438. 1992

The chacma baboon as an organ donor for man.  53:1380-1381. 1992

The effect of erythropoietin and blood transfusions on highly sensitized patients on a single cadaver renal allograft waiting list.  53:363-368. 1992

The impact of the UNOS mandatory sharing policy on recipients of the black and white races-experience at a single renal transplant center.  53:770-774. 1992

Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients.  51:70-75. 1991

Problems with therapeutic monitoring of cyclosporine using silicone central venous line samples.  52:1109-1110. 1991

Survival of ganciclovir-treated heart transplant recipients with cytomegalovirus pneumonitis.  52:910-913. 1991

Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient.  49:311-316. 1990

Exquisite sensitivity of dendritic cells to ultraviolet radiation and temperature changes.  48:666-671. 1989

Functional and morphological studies of long-term islet allografts in the renal subcapsular space of the BB/W rat.  47:580-582. 1989

Pituitary function in brain-dead patients.  48:1078-1079. 1989

Successful renal allografts in recipients with crossmatch-positive, dithioerythritol-treated negative sera: Race, transplant history, and HLA-DR1 phenotype.  47:240-245. 1989

Use of cryopreserved donor bone marrow in cadaver kidney allograft recipients.  47:66-71. 1989

Xenograft transplantation.  47:408. 1989

Xenotransplantation.  47:747. 1989

Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy.  45:32-36. 1988

Injury of myocardial conduction tissue and coronary artery smooth muscle following brain death in the baboon.  45:964-966. 1988

Thyroid function in human cardiac allograft donors.  45:671-672. 1988

Donor-specific transfusions in renal transplantation in children effect of azathioprine plus transfusions.  44:159-161. 1987

Effect of low-temperature culture and site of transplantation on hamster islet xenograft survival (Hamster to mouse).  44:465-468. 1987

Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors.  43:852-854. 1987

Loss of myocardial viability following hypothermic perfusion storage from contaminating trace elements in the perfusate.  43:23-28. 1987

Primary integumentary allograft reactivity in the American cockroach, periplaneta Americana.  43:514-519. 1987

Impairment of renal slice function following brain death, with reversibility of injury by hormonal therapy.  41:29-32. 1986

Lethal Graft-Vkrsus-Host disease in a recipient of a pancreas-spleen transplant.  41:544-546. 1986

Failure of pretransplant third-party and preoperative donor-specific blood transfusion to improve heterotopic cardiac allograft survival in baboons.  40:569-571. 1985

Prolonged survival of donor skin grafts on mice bearing established islet of langerhans transplants.  40:216-218. 1985

Immunosuppression in the baboon cardiac allograft model: Effects of splenectomy, bolus methylprednisolone, propranolol, high–dose azathioprine, cyclophosphamide, and a niridazole metabolite.  38:299-300. 1984

Primary integumentary xenograft reactivity in the american cockroach, periplaneta Americana.  37:478-484. 1984

Reactivity of lymphocyte cytotoxic autoantibodies from renal patients with cell line K562.  38:557-558. 1984

Possibility of graft-vs-leukemia determinants independent of the major histocompatibility complex in allogeneic marrow transplantation.  35:378-385. 1983

Successful renal transplantation despite warm B cell antibodies.  36:207-209. 1983

Low-dose versus high-dose steroid therapy in the prevention of acute rejection in baboon heterotopic cardiac allografts.  34:107-108. 1982

Qa-1-associated antigens: IV. Evidence for additional Qa-1 polymorphism defined biochemically and by cytotoxic T lymphocyte recognition.  34:54-59. 1982

Twenty-four-hour preservation of the pig heart by a portable hypothermic perfusion system.  34:246-250. 1982

An investigation of the immunosuppressive effects of niridazole and metronidazole in rat and baboon heterotopic cardiac allograft models.  31:326. 1981

Fatal response suggestive of graft-versus-host reaction following transplantation of spleen cells from allogeneic athymic (Nude) donors.  31:201-204. 1981

Improved renal function using adenosine triphosphate-magnesium chloride in preservation of canine kidneys subjected to warm ischemia.  31:187-189. 1981

Exponential relationship between spleen cell concentration and fatal graft-versus-host response after transplantation of allogeneic spleen-marrow cell mixtures.  29:507-510. 1980

Percutaneous transluminal dilation in renal transplant arterial stenosis.  30:440-444. 1980

Effect of primary and recurrent cytomegalovirus infections upon graft and patient survival after renal transplantation..  28:443-446. 1979

Effect of primary and recurrent cytomegalovirus infections upon graft and patient survival after renal transplantation.  27:443-450. 1979

Ia and H-2 antigens on blast cells.  19:528-530. 1975